{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:11:54Z","timestamp":1792512714083,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12308-025-00656-4","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T23:52:00Z","timestamp":1757375520000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immune cell subset variations in immune thrombocytopenia: a prospective observational study"],"prefix":"10.1007","volume":"18","author":[{"given":"Kartik A.","family":"Purohit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Kotwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmita","family":"Dass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"key":"656_CR1","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1056\/NEJMra010501","volume":"346","author":"DB Cines","year":"2002","unstructured":"Cines DB, Blanchette VS (2002) Immune thrombocytopenic purpura. N Engl J Med 346:995\u20131008","journal-title":"N Engl J Med"},{"key":"656_CR2","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1172\/JCI4238","volume":"102","author":"M Kuwana","year":"1998","unstructured":"Kuwana M, Kaburaki J, Ikeda Y (1998) Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody. J Clin Invest 102:1393\u20131402","journal-title":"J Clin Invest"},{"key":"656_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm6020016","author":"A Zufferey","year":"2017","unstructured":"Zufferey A, Kapur R, Semple JW (2017) Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med. https:\/\/doi.org\/10.3390\/jcm6020016","journal-title":"J Clin Med"},{"key":"656_CR4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1182\/asheducation-2018.1.561","volume":"2018","author":"JG Kelton","year":"2018","unstructured":"Kelton JG, Vrbensky JR, Arnold DM (2018) How do we diagnose immune thrombocytopenia in 2018? Hematology 2018:561\u2013567","journal-title":"Hematology"},{"key":"656_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1600-0609.2006.00780.x","volume":"78","author":"B Liu","year":"2007","unstructured":"Liu B, Zhao H, Poon M-C, Han Z, Gu D, Xu M et al (2007) Abnormality of CD4+CD25+ regulatory T cells in idiopathic thrombocytopenic purpura. Eur J Haematol 78:139\u2013143","journal-title":"Eur J Haematol"},{"key":"656_CR6","unstructured":"Arandi N, Mirshafiey A, Jeddi-Tehrani M, Shaghaghi M, Sadeghi B, Abolhassani H et al (1970) Alteration in frequency and function of CD4+CD25+FOXP3+ regulatory T cells in patients with immune thrombocytopenic purpura. Iran J Allergy Asthma Immunol [Internet]. [cited 2019 May 3];13. Available from: http:\/\/ijaai.tums.ac.ir\/index.php\/ijaai\/article\/view\/472"},{"key":"656_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/cei.12279","volume":"176","author":"RM Talaat","year":"2014","unstructured":"Talaat RM, Elmaghraby AM, Barakat SS, El-Shahat M (2014) Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP). Clin Exp Immunol 176:291\u2013300","journal-title":"Clin Exp Immunol"},{"key":"656_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/bjh.12480","volume":"163","author":"CGJ McKenzie","year":"2013","unstructured":"McKenzie CGJ, Guo L, Freedman J, Semple JW (2013) Cellular immune dysfunction in immune thrombocytopenia (ITP). Br J Haematol 163:10\u201323","journal-title":"Br J Haematol"},{"key":"656_CR9","doi-asserted-by":"crossref","unstructured":"Verschoor A, Langer HF (2013) Crosstalk between platelets and the complement system in immune protection and disease [Internet]. Vol. 110, Thrombosis and haemostasis. Thromb Haemost [cited 2020 Dec 3]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24008927\/","DOI":"10.1160\/TH13-02-0102"},{"key":"656_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12185-010-0753-z","volume":"93","author":"Z Li","year":"2011","unstructured":"Li Z, Mou W, Lu G, Cao J, He X, Pan X et al (2011) Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia. Int J Hematol 93:91\u201398","journal-title":"Int J Hematol"},{"key":"656_CR11","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","volume":"113","author":"F Rodeghiero","year":"2009","unstructured":"Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM et al (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113:2386\u20132393","journal-title":"Blood"},{"key":"656_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.hemonc.2017.01.001","volume":"10","author":"FH El-Rashedi","year":"2017","unstructured":"El-Rashedi FH, El-Hawy MA, Helwa MA, Abd-Allah SS (2017) Study of CD4+, CD8+, and natural killer cells (CD16+, CD56+) in children with immune thrombocytopenic purpura. Hematol Oncol Stem Cell Ther 10:8\u201314","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"656_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3892\/etm.2013.1386","volume":"7","author":"R Xu","year":"2014","unstructured":"Xu R, Zheng Z, Ma Y, Hu Y, Zhuang S, Wei B et al (2014) Elevated NKT cell levels in adults with severe chronic immune thrombocytopenia. Exp Ther Med 7:149\u2013154","journal-title":"Exp Ther Med"},{"key":"656_CR14","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/j.1365-2141.2004.04896.x","volume":"125","author":"U Johansson","year":"2004","unstructured":"Johansson U, Macey MG, Kenny D, Provan D, Newland AC (2004) \u03b1-galactosylceramide-driven expansion of human natural killer T cells is inhibited by prednisolone treatment. Br J Haematol 125:400\u2013404","journal-title":"Br J Haematol"},{"key":"656_CR15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.thromres.2006.09.008","volume":"120","author":"M Sakakura","year":"2007","unstructured":"Sakakura M, Wada H, Tawara I, Nobori T, Sugiyama T, Sagawa N et al (2007) Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura. Thromb Res 120:187\u2013193","journal-title":"Thromb Res"},{"key":"656_CR16","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.1182\/blood-2010-04-281717","volume":"116","author":"W Bao","year":"2010","unstructured":"Bao W, Bussel JB, Heck S, He W, Karpoff M, Boulad N et al (2010) Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents. Blood 116:4639\u20134645","journal-title":"Blood"},{"key":"656_CR17","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1002\/ajh.25989","volume":"95","author":"Y Yu","year":"2020","unstructured":"Yu Y, Wang M, Hou Y, Qin P, Zeng Q, Yu W et al (2020) High-dose dexamethasone plus recombinant human thrombopoietin vs high-dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: a prospective, multicenter, randomized trial. Am J Hematol 95:1542\u20131552","journal-title":"Am J Hematol"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-025-00656-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-025-00656-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-025-00656-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:02:42Z","timestamp":1788912162000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-025-00656-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["656"],"URL":"https:\/\/doi.org\/10.1007\/s12308-025-00656-4","relation":{},"ISSN":["1868-9256","1865-5785"],"issn-type":[{"value":"1868-9256","type":"print"},{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,9]]},"assertion":[{"value":"24 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study protocol was reviewed and approved by the Institutional Ethics Committee, approval number EC\/08\/17\/1240.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all the patients who agreed to participate in this study.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication of their clinical details and images was obtained from the patients.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"41"}}